Your browser doesn't support javascript.
loading
On-Chip Magnetic Extraction of Circulating Cell-Free DNA from Biological Samples.
Perez-Toralla, Karla; Pereiro, Iago; Garrigou, Sonia; Di Federico, Fahima; Araya-Farias, Monica; Proudhon, Charlotte; Bidard, François-Clémént; Viovy, Jean-Louis; Taly, Valérie; Descroix, Stéphanie.
Affiliation
  • Perez-Toralla K; Université Paris-Saclay, CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SPI, Gif-sur-Yvette, France. karla.pereztoralla@cea.fr.
  • Pereiro I; Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
  • Garrigou S; Institut Curie, PSL Research University, Paris, France.
  • Di Federico F; Institut Pierre-Gilles de Gennes for Microfluidics (IPGG), Paris, France.
  • Araya-Farias M; Université Sorbonne Paris Cité, INSERM UMRS 1147, CNRS SNC, Translational Research and Microfluidics, Equipe labellisée Ligue Nationale Contre le Cancer, Paris, France.
  • Proudhon C; Sorbonne Universités, UPMC Univ Paris 06, Paris, France.
  • Bidard FC; Institut Curie, PSL Research University, Paris, France.
  • Viovy JL; Université Paris-Saclay, CEA, INRAE, Médicaments et Technologies pour la Santé (MTS), SPI, Gif-sur-Yvette, France.
  • Taly V; Univ Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
  • Descroix S; Circulating Tumor Biomarkers Laboratory, SiRIC, Translational Research Department, Institut Curie, PSL Research University, Paris, France.
Methods Mol Biol ; 2804: 65-75, 2024.
Article in En | MEDLINE | ID: mdl-38753140
ABSTRACT
In recent years, the analysis of circulating cell-free DNA (cfDNA) containing tumor-derived DNA has emerged as a noninvasive means for cancer monitoring and personalized medicine. However, the isolation of cfDNA from peripheral blood has remained a challenge due to the low abundance and high fragmentation of these molecules. Here, we present a dynamic Magnetic ExTRactiOn (METRO) protocol using microfluidic fluidized bed technology to isolate circulating cfDNA from raw biological materials such as undiluted serum. This protocol maximizes the surface area for DNA binding within the chip in order to capture short DNA fragments. It uses only a few µL of sample and reagents. The protocol can be automated, and it is fully compatible with sensitive DNA amplification methods such as droplet-based digital PCR (ddPCR).
Subject(s)
Key words

Full text: 1 Database: MEDLINE Main subject: Lab-On-A-Chip Devices / Cell-Free Nucleic Acids Limits: Humans Language: En Year: 2024 Type: Article

Full text: 1 Database: MEDLINE Main subject: Lab-On-A-Chip Devices / Cell-Free Nucleic Acids Limits: Humans Language: En Year: 2024 Type: Article